- Home
- CRBP vs SGC Comparison
CRBP vs SGC Comparison
Compare CRBP & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- SGC
- Stock Information
- Founded
- CRBP 2009
- SGC 1920
- Country
- CRBP United States
- SGC United States
- Employees
- CRBP N/A
- SGC N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- SGC Apparel
- Sector
- CRBP Health Care
- SGC Consumer Discretionary
- Exchange
- CRBP Nasdaq
- SGC Nasdaq
- Market Cap
- CRBP 227.3M
- SGC 252.6M
- IPO Year
- CRBP N/A
- SGC N/A
- Fundamental
- Price
- CRBP $16.73
- SGC $16.46
- Analyst Decision
- CRBP Strong Buy
- SGC Strong Buy
- Analyst Count
- CRBP 7
- SGC 2
- Target Price
- CRBP $65.86
- SGC $22.50
- AVG Volume (30 Days)
- CRBP 346.4K
- SGC 52.7K
- Earning Date
- CRBP 11-07-2024
- SGC 11-06-2024
- Dividend Yield
- CRBP N/A
- SGC 3.39%
- EPS Growth
- CRBP N/A
- SGC 79.86
- EPS
- CRBP N/A
- SGC 0.82
- Revenue
- CRBP N/A
- SGC $567,509,000.00
- Revenue This Year
- CRBP N/A
- SGC $5.05
- Revenue Next Year
- CRBP N/A
- SGC $4.03
- P/E Ratio
- CRBP N/A
- SGC $20.16
- Revenue Growth
- CRBP N/A
- SGC 4.19
- 52 Week Low
- CRBP $4.00
- SGC $11.08
- 52 Week High
- CRBP $61.90
- SGC $21.80
- Technical
- Relative Strength Index (RSI)
- CRBP 37.25
- SGC 56.33
- Support Level
- CRBP $15.65
- SGC $16.07
- Resistance Level
- CRBP $17.18
- SGC $16.67
- Average True Range (ATR)
- CRBP 1.26
- SGC 0.56
- MACD
- CRBP 0.35
- SGC -0.03
- Stochastic Oscillator
- CRBP 21.09
- SGC 44.20
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.